Endovascular Treatment of Claudication due to Isolated Internal Iliac Artery Occlusive Disease

Michael B Brewer1, David L Lau1, James T Lee2

  • 1Vascular & Endovascular Surgery, Department of Surgery, Kaiser Permanente Downey Medical Center, Downey, CA.

Insights

Isolated internal iliac artery stenosis can cause buttock claudication despite normal pulses. Drug-eluting balloon angioplasty offers a successful treatment for this challenging vascular condition.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Medical Diagnostics

Background:

  • Aortoiliac occlusive disease commonly causes lower extremity claudication, typically presenting with diminished pulses and abnormal vascular studies.
  • Isolated internal iliac artery stenosis is less common but can mimic these symptoms, affecting the buttocks, hips, or thighs.
  • Diagnosis can be challenging due to normal lower extremity findings, potentially misdirecting clinical suspicion away from vascular causes.

Observation:

  • A case of disabling buttock claudication in a patient with normal pulses and isolated ipsilateral internal iliac artery stenosis is presented.
  • The patient's symptoms were successfully treated with drug-eluting balloon angioplasty.
  • This highlights a less common but treatable cause of claudication.

Findings:

  • Internal iliac artery stenosis can present atypically with normal peripheral vascular examinations.
  • Drug-eluting balloon angioplasty is an effective endovascular treatment for isolated internal iliac artery stenosis.
  • Literature review supports angioplasty as a viable option for similar cases.

Implications:

  • Increased awareness of isolated internal iliac artery stenosis is crucial for accurate diagnosis of buttock claudication.
  • Endovascular techniques like angioplasty provide effective treatment options for this condition.
  • This case contributes to understanding the spectrum of iliac artery disease and its management.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
963
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
387
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283